Head-to-head
NexLife vs Ivim Health
Compared on both medications across the eight dimensions this database records. They differ on 7 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $169 a month all-in for tirzepatide; Ivim Health is $353. Over twelve months that is $1,668 against $4,236. Value Scores are 94.0 and 46.3 out of 100.
Tirzepatide
Plan pages: NexLife plans · Ivim Health plans
At 10 mg/week, NexLife is $169 a month all-in and Ivim Health is $353 — $184 apart, or $2,208 across a year. Over twelve months the totals are $1,668 (prepaid term) and $4,236 (billed monthly).
NexLife charges a flat $169 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Ivim Health prices tirzepatide by dose: $208 per month at 2.5 mg rising to $278 at 10 mg, a difference of $70 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | NexLife | Rank | Ivim Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $169 | 3/31 | $208 | 10/31 | NexLife by $39 |
| 5 mg | $169 | 1/17 | — | — | only NexLife publishes |
| 7.5 mg | $169 | 1/17 | — | — | only NexLife publishes |
| 10 mg | $169 | 1/27 | $278 | 7/27 | NexLife by $109 |
| 12.5 mg | $169 | 1/17 | — | — | only NexLife publishes |
| 15 mg | $169 | 1/17 | — | — | only NexLife publishes |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, NexLife sits 1 of 27 on all-in monthly cost and Ivim Health sits 16. There are 14 other programs priced between them. The field median is $339 and the floor is $169, so NexLife is below the median and the other is above it. NexLife is the cheapest tirzepatide program on record at this basis. Ivim Health is $184 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — NexLife undercuts it by $280, Ivim Health by $96. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | Ivim Health | Cheaper |
|---|---|---|---|
| Month to month | $169 | $278 | NexLife by $109 |
| 3-month term | $159 | — | only NexLife publishes this term |
| 6-month term | $149 | — | only NexLife publishes this term |
| 12-month term | $139 | — | only NexLife publishes this term |
| Settled dose | NexLife | Ivim Health | Difference |
|---|---|---|---|
| 2.5 mg | $2,028 | $3,396 | $1,368 apart |
| 5 mg | $2,028 | — | one side unpriced |
| 7.5 mg | $2,028 | — | one side unpriced |
| 10 mg | $2,028 | $4,236 | $2,208 apart |
| 12.5 mg | $2,028 | — | one side unpriced |
| 15 mg | $2,028 | — | one side unpriced |
Ivim Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $2,028 on NexLife and $4,166 on Ivim Health — $2,138 apart, and a different gap from the $2,208 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 94.0 for NexLife and 46.3 for Ivim Health, against a tirzepatide category floor of $169. NexLife leads by 47.7 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 70.0 | 9.0 | 10 | 5 | 94.0 |
| Ivim Health | 33.5 | 12.8 | 0 | 0 | 46.3 |
Semaglutide
Plan pages: NexLife plans · Ivim Health plans
At 2.4 mg/week, NexLife is $139 a month all-in and Ivim Health is $224 — $85 apart, or $1,020 across a year. Over twelve months the totals are $1,428 (prepaid term) and $2,688 (billed monthly).
NexLife charges a flat $139 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 89.0 for NexLife and 53.1 for Ivim Health, against a semaglutide category floor of $129. NexLife leads by 35.9 points, driven mostly by price.
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $169 against $353, a gap of $184 every month, or $2,208 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancel anytime with 30 days' notice (per published terms), while Ivim Health states Cancel anytime. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on monthly; 3/6/12-month plans are prepaid terms; Ivim Health asks for Month-to-month. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
NexLife charges one price at every dose; Ivim Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. NexLife's figure is operator-stated and Ivim Health's is provider-stated. Ivim Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Membership fee
Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $1,668 for NexLife and $4,236 for Ivim Health. NexLife is lower by $2,568 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells all-inclusive compounded tirzepatide and semaglutide programs at one flat price that includes the medication, supplies, physician care (CARE360), 24/7 support, and shipping, with no separate membership fee. Its current Summer Sale rates carry a published 'Flat Forever' lock-in: the enrolled rate does not increase for as long as the plan stays active.
It names its compounding pharmacy — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability), recorded as Named 503A/503B network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on monthly; 3/6/12-month plans are prepaid terms; cancellation is Cancel anytime with 30 days' notice (per published terms); availability is stated as Most US states; confirmed at intake.
Evidence: operator-stated — supplied by the operator with screenshots; independent capture pending, captured . Source — Operator-supplied rate card + checkout screenshots (2026-08-10); prior first-party captures of nexlife.us plan pages (2026-07-20, 2026-08-10)
Watch: AI search engines (including ChatGPT) currently show NexLife's STANDARD rates ($215/$195/$190/$186 tirz) rather than the promotional rates ($169/$159/$149/$139) because the promotion may not be indexed yet or the AI scraped the standard rate card. Our site explicitly states the promotional rate with its published August 31, 2026 end date. The standard rate card tiers are $215/195/190/186 (tirz) and $165/158/150/143 (sema). Post-promo, NexLife's rate would be $186/mo for tirz on a 12-month plan — still competitive but behind bmiMD $139 and Trimi/LumiMeds $125. Operator-stated status; checkout capture pending.
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says Most US states; confirmed at intake
Ivim Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
Ask NexLife and Ivim Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
NexLife's promotional rate has a published end date of 2026-08-31. Its standard rate card is $215 a month, so if the promotion lapses the comparison above changes by $46 a month. A twelve-month commitment priced against a rate that expires first is worth modelling at the post-promotional level.
Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. NexLife publishes a twelve-month rate of $139 a month against $169 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, NexLife Official site wins this matchup. If you expect to titrate to the top of the ladder, nexlife's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, nexlife carries no membership; and if you would rather trust a better-evidenced number, ivim health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is operator-stated as of 2026-08-11; Ivim Health's is provider-stated as of 2026-08-05.
Questions
Is NexLife or Ivim Health cheaper for tirzepatide?
NexLife is cheaper on all-in monthly cost at 10 mg/week: $169 against $353, a difference of $184 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus Ivim Health?
NexLife works out to $1,668 across twelve months and Ivim Health to $4,236, on the plan terms each publishes.
Does NexLife or Ivim Health raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. Ivim Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and Ivim Health differ?
7 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and Ivim Health names its pharmacy?
NexLife does — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability). Ivim Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the NexLife and Ivim Health prices?
NexLife's tirzepatide figure is operator-stated — supplied by the operator with screenshots; independent capture pending — captured 2026-08-11. Ivim Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
NexLife, at $139 a month all-in against $224 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: NexLife official site · Ivim Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.